Novo Integrated Sciences Inc 2023年度报告

FORM 10-K ⅓ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGEACT OF 1934 For the fiscal year ended August 31, 2024 ⅓TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGEACT OF 1934 For the transition period from ______, 20 ____, to ______, 20_____. Commission File Number 001-40089 Novo Integrated Sciences, Inc.(Exact Name of Registrant as Specified in its Charter) Nevada59-3691650(State or Other Jurisdiction of(I.R.S. Employer Incorporation or Organization)Identification No.) 11120 NE 2nd Street, Suite 100Bellevue, Washington98004(Address of Principal Executive Offices)(Zip Code) (206) 617-9797(Registrant’s Telephone Number, Including Area Code) N/A(Former name or former address and former fiscal year, if changed since last report) Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the SecuritiesAct. Yes⅓No⅓ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of theAct. Yes⅓No⅓ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) ofthe Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes⅓No⅓ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to besubmitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or forsuch shorter period that the registrant was required to submit such files). Yes⅓No⅓ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer,a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,”“accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the ExchangeAct. (Check one): Large accelerated filer⅓Accelerated filer⅓Non-accelerated filer⅓Smaller reporting company⅓Emerging growth company⅓ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extendedtransition period for complying with any new or revised financial accounting standards provided pursuant to Section13(a) of the Exchange Act.⅓ Indicate by check mark whether the registrant has filed a report on an attestation to its management’s assessment ofthe effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.⅓ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financialstatements of the registrant included in the filing reflect the correction of an error to previously issued financialstatements.⅓ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis ofincentive-based compensation received by any of the registrant’s executive officers during the relevant recoveryperiod pursuant to §240.10D-1(b).⅓ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes⅓No⅓ The aggregate market value of the voting and non-voting common equity held by non-affiliates computed byreference to the price at which the common equity was last sold, or the average bid and asked price of such commonequity, as of the last business day of the registrant’s most recently completed second fiscal quarter, February 29,2024, was $10,240,619. There were 19,730,247 shares of the registrant’s common stock, $0.001 par value per share, outstanding as ofDecember 17, 2024. Documents Incorporated by Reference None Novo Integrated Sciences, Inc. Cautionary Statement Regarding Forward-Looking StatementsItem 1.Business1Item 1A.Risk Factors41Item 1B.Unresolved Staff Comments79Item 1C.Cybersecurity79Item 2.Properties80Item 3.Legal Proceedings81Item 4.Mine Safety Disclosures81 Item 5.Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchasesof Equity Securities81Item 6.[Reserved]82Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operations83Item 7A.Quantitative and Qualitative Disclosures About Market Risk101Item 8.Financial Statements and Supplementary Data102Item 9.Changes in and Disagreements with Accountants on Accounting and Financial Disclosure103Item 9A.Controls and Procedures103Item 9B.Other Information103Item 9C.Disclosure Regarding Foreign Jurisdictions that Prevent Inspections103 CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS This Annual Report on Form 10-K and the documents incorporated herein by reference con